EMA to Continue Patient Engagement Efforts in Assessments

Drug Industry Daily
A A
The EMA says it will continue to invite patients to in-person discussions between reviewers and product sponsors — following a successful two-year pilot project involving five medicines.

To View This Article:

Login

Subscribe To Drug Industry Daily